Uncontrolled diabetes poses a significant risk for developing Metabolically Dysregulated-Associated Steatotic Liver Disease (MASLD), which includes conditions like liver fibrosis and cirrhosis. A study published in The Lancet Regional Health Southeast Asia found that one in four adults with type 2 diabetes in India suffers from liver fibrosis, while one in twenty has probable cirrhosis. The study emphasizes that fibrosis should be the primary focus in diabetes care, necessitating the integration of fibrosis screening into diabetes management programs. The mechanisms linking diabetes to liver disease include fat accumulation, oxidative stress, and inflammation, leading to conditions like Metabolic Dysfunction-Associated Steatohepatitis (MASH) and increased cancer risk. Preventive measures such as regular monitoring of liver function, weight management, a balanced diet, regular exercise, and controlling blood sugar levels are essential for reducing liver disease risk. Additionally, avoiding alcohol and managing other health conditions associated with metabolic syndrome can further protect liver health.